Update on the discovery of efflux pump inhibitors against critical priority gram-negative bacteria

HIGHLIGHTS

• who: Nina Compagne and collaborators from the UnivLille, Inserm, Institut Pasteur de Lille, Drugs and Molecules for Living Systems, Lille, France Institute of Biochemistry, Goethe-University Frankfurt, Max-von-Laue-Str, have published the paper: Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria, in the Journal: Antibiotics 2023, 12, x FOR PEER REVIEW of /2023/
• what: A total of eight inhibitor classes with This review focuses on synthetic RND efflux inhibitors that target relationships, the RND core validated target-specific effects are described for pump their (i) structure-activity . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.